Clinical trial
Efficacy and Safety of Preemptive Intravenous Dexamethasone in MIS-TLIF
NCT06367855 is registered in ClinicalTrials.gov with Potsawat Surabotsopon as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Efficacy and Safety of Preemptive Intravenous Dexamethasone in MIS-TLIF
- Lead sponsor
- Potsawat Surabotsopon
- Phase
- Phase 4
- Overall status
- Recruiting
- Start date
- May 1, 2024
- Completion date
- December 31, 2025
- Enrollment
- 60 (estimated)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
disc degeneration, disc disease, fusion of spine, spinal stenosis lumbar, surgery